Net profit of Jubilant Pharmova rose 64.48% to Rs 102.80 crore in the quarter ended September 2024 as against Rs 62.50 crore during the previous quarter ended September 2023. Sales rose 4.53% to Rs 1742.20 crore in the quarter ended September 2024 as against Rs 1666.70 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 1742.20 | 1666.70 | 5 |
| OPM % | 16.61 | 14.51 | - |
| PBDT | 250.00 | 194.60 | 28 |
| PBT | 158.60 | 98.00 | 62 |
| NP | 102.80 | 62.50 | 64 |